可生物降解聚合物乙肝疫苗微球的制备和表征

采用双乳液体系（Ｗ１／Ｏ／Ｗ２）溶剂抽提法制备了聚－ＤＬ－乳酸－聚乙二醇嵌段共聚物（Ｐｏｌｙ－ｄｌｌａｃｔｉｄｅ－ｂ－ｐｏｌｙｅｔｈｙｌｅｎｅ ｇｌｙｃｏｌ,ＰＥＬＡ）包裹乙肝表面抗原（ＨＢｓＡｇ）微球。微球外观规整,平均粒径２．１７μｍ,抗原包裹量达１．２５％,包裹效率７１．８％。经聚丙烯酰胺凝胶电泳（ＰＡＧＥ）检测,ＨＢｓＡｇ在微球制备过程中保持了结构完整性。以乙肝常规铝佐剂疫苗为对照,ＢＡＬ     

微米级聚酯醚嵌段共聚物微球的制备及其蛋白包裹研究

聚酯 醚嵌段共聚物聚 Ｄ，Ｌ 乳酸 聚乙二醇（Ｐｏｌｙ ＤＬ ｌａｃｔｉｄｅ Ｐｏｌｙｅｔｈｙｌｅｎｅｇｌｙｃｏｌ，ＰＬＡ ＰＥＧ）采用本体聚合法在１８０℃及－９５×１０－２ＭＰａ条件下制得．光谱分析证实产物结构．采用乳液溶剂蒸发法制备ＰＬＡ ＰＥＧ微球，粒径＜５μｍ．以复合乳液技术包裹蛋白．差示扫描量热分析确证ＰＬＡ ＰＥＧ有效包裹蛋白．ＢＣＡ法检测微球蛋白含量．结果表明与均聚物ＰＬＡ比较，ＰＬＡ ＰＥＧ不仅改善了成球条件而且蛋白的包裹效率明显提高．     

钛(Ⅳ)-5-Br-PADAP-NaClO_3体系极谱吸附催化波的研究

２－（５－溴－２－吡啶偶氮）－５－二乙氨基苯酚（５－Ｂｒ－ＰＡＤＡＰ）在极谱和伏安分析中的应用已有一些报道。陈林林等曾经研究过Ｔｉ（Ⅳ）－５－Ｂｒ－ＰＡＤＡＰ络合物在稀Ｈ２ＳＯ４－Ｈ２Ｃ２Ｏ４溶液中的极谱行为,但灵敏度不高（１．０×１０－７ｍｏｌ／Ｌ）。我们发现,在ｐＨ４．１左右的ＨＡｃ－ＮａＡｃ底液中,Ｔｉ（Ⅳ）－５－Ｂｒ－ＰＡＤＡＰ－ＮａＣｌＯ３体系产生一灵敏的极谱吸附催化波,二次导数峰电位在－０．８６Ｖ（ｖｓ．ＳＣＥ）左右,波形良好,波高稳定,检测限可达４×１０－１０ｍｏｌ／Ｌ。１　实验部…     

混合微乳液的增敏作用研究：Cd（Ⅱ）—5—Br—PADAP的分光光度测定

研究了在Ｏ／Ｗ混合微乳液ＳＤＳ－ＯＰ／ｎＣ４Ｈ９ＯＨ／ｎ－Ｃ７Ｈ１６／Ｈ２Ｏ介质中，Ｃｄ（Ⅱ）－５－Ｂｒ－ＰＡＤＡＰ的显色反应。结果表明显色反应的灵敏度较单一的ＳＤＳ微乳液，单一的ＯＰ的微乳液，混合ＳＤＳ－ＯＰ胶束的介质中，具有更好的增敏作用和稳定性，Ｃｄ浓度在０－５μｇ／１００ｍＬ范围内符合比尔定律。方法用于废水和环境水样中微量Ｃｄ的测定，结果满意。     

紫外分光光度-CPA矩阵法同时测定2-(2′-呋喃基)苯并咪唑和邻苯二胺

研究了２－（２′－呋喃基）苯并咪唑（ＦＢＤ）和邻苯二胺（ＯＰＡ）在无水乙醇溶液中的紫外吸收光谱，建立了多波长同时测定ＦＢＤ和ＯＰＡ的紫外光度ＣＰＡ矩阵法。ＦＢＤ和ＯＰＡ分别在０．１～１０ｍｇ／Ｌ和１．０～１００ｍｇ／Ｌ的浓度范围，ＦＢＤ和ＯＰＡ的回收率均大于９３％，相对标准偏差小于７．５％。     

CONVERSION OF KETONES INTO1，1－DISUBSTITUTED－2，3，3－TRIFLUORO－2－PROPEN －1－OLSWITH1，1－DIBROMO－1，2，2，2－TETRLUORO ETHANE／MAGNESIUM REAGENT

ＣＯＮＶＥＲＳＩＯＮ　ＯＦ　ＫＥＴＯＮＥＳ　ＩＮＴＯ１，１－ＤＩＳＵＢＳＴＩＴＵＴＥＤ－２，３，３－ＴＲＩＦＬＵＯＲＯ－２－ＰＲＯＰＥＮ　－１－ＯＬＳＷＩＴＨ１，１－ＤＩＢＲＯＭＯ－１，２，２，２－ＴＥＴＲＬＵＯＲＯ　ＥＴＨＡＮＥ／ＭＡＧＮＥＳＩＵＭ...     

丁基罗丹明B-铜钨杂多酸光度法测定微量铜

在聚乙烯醇（ＰＶＡ）存在下，丁基罗丹明Ｂ（ＢＲＢ）与铜钨杂多酸形成离子缔合物。缔合物的形成条件为ｃＨ２ＳＯ４＝１．２ｍｏｌ／Ｌ，ｃＷＯ２－４＝６．１×１０－５ｍｏｌ／Ｌ，ｃＢＲＢ＝３．８×１０－５ｍｏｌ／Ｌ和ＰＶＡ０．０８％。缔合物的最大吸收波长位于５７０ｎｍ，摩尔吸光系数ε＝１．６６×１０６Ｌ·ｍｏｌ－１·ｃｍ－１，铜量在每２５ｍＬ０～０．５μｇ范围内服从比耳定律，检测限为每ｍＬ０．６５ｎｇ（ｎ＝１２），对每ｍＬ１８ｎｇＣｕ测定的ＲＳＤ为０．８５％（ｎ＝１０）。缔合物至少稳定１５０ｈ，其摩尔比为Ｃｕ∶Ｗ∶ＢＲＢ＝１∶１２∶５，红外图谱表明铜钨杂多酸具有Ｋｅｇｇｉｎ结构。考察了４０多种共存离子的影响，大多数常见元素不干扰。本法已用于天然水、自来水、降水、人发、中药和蔬菜中铜的测定，结果满意。     

微乳液的增敏作用研究：Ni（Ⅱ）—5—Br—PADAP的分光光度法测定

以含水量８０％的阴离了了型ＳＤＳ／ｎ－Ｃ５Ｈ１１ＯＨ／ｎ－Ｃ７Ｈ１６／Ｈ２Ｏ微乳液为介质，进行了Ｎｉ（Ⅱ）－５－Ｂｒ－ＰＡＤＡＰ分光光度研究，其表观摩尔吸光系数为１．１３×１０＾５Ｌ．ｍｏｌ＾－１．ｃｍ＾－１，与相应含水量的ＳＤＳ胶束介质比较，测定灵敏度显著提高，样品分析令人满意。     

非离子型微乳液的增敏作用研究——Cd（Ⅱ）—5—Br—PADAP吸光光 …

在含水量９０％的非离子型微乳液－－乳化剂ＯＰ／正丁醇／正庚烷／水中,以５－Ｂｒ－ＰＡＤＡＰ为显色剂,吸光光度法测定镉,结果表明,络合物的λｍａｘ为５６５ｎｍ,摩尔吸光系数这２．１４×１０＾５Ｌ·ｍｏｌ＾－１ｃｍ＾－１,与相同含水量的乳化剂ＯＰ胶束体系相比,测定灵敏度明显提高,试验条件有所改善,镉含量在０－８．０μｇ／１０ｍｌ范围符合比耳定律。     

锡钨杂多酸-耐尔蓝光度法测定纳克量锡

本文报道一个光度法测定纳克量锡的新方法。在聚乙烯醇（ＰＶＡ）存在下锡（Ⅳ）与钨酸盐和耐尔蓝（ＮＢ）反应形成离子缔合物,离子缔合物的最大吸收位于５８０ｎｍ,表观摩尔吸光系数ε值２．９５×１０７Ｌ·ｍｏ１－１·ｃｍ－１,服从比耳定律范围０～２．０μｇ／Ｌ,检出限（３σ）０．０８３μｇ／Ｌ（ｎ＝１０）,对２．０μｇ／Ｌ锡测定的ＲＳＤ为１．４２％（ｎ＝１１）,离子缔合物至少稳定７２ｈ。考察了４０多种共存离子的影响,大多数常见元素不干扰。测定锡的适宜条件［Ｈ２ＳＯ４］＝１．２０ｍｏ１／Ｌ,［ＷＯ２－４］＝６．０５×１０－５ｍｏ１／Ｌ,［ＮＢ］＝５．５×１０－５ｍｏ１／Ｌ和ＰＶＡ０．０８％。本法已用于某些合金钢和锌合金中纳克量锡的测定,结果与推荐值吻合,回收率满意。     

Microencapsulation of bovine hemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique

This study focused on the influences of solvent removal method and wall polymer composition on microspheres characteristics in W/O/W double emulsion procedure. Monomethoxypoly(ethylene glycol)-b-poly- -lactide (PELA) microspheres containing bovine hemoglobin (BHb, a model protein) were prepared by four solvent removal methods, including solvent-evaporation at atmosphere, at reduced pressure, solvent-extraction and solvent-diffusion methods, where the last method used ethyl acetate (EA) as organic solvent and the others used methylene chloride (MC). The bio-activity of encapsulated BHb, encapsulation efficiency, particle size and surface morphology of microspheres were evaluated in relation to the influences of solvent removal method and PELA composition. BHb encapsulated by the W/O/W double emulsion–solvent diffusion method with EA as organic solvent displayed a bio-activity near to that of native BHb. The efficiency of BHb entrapment achieved by this method was much higher than those by other methods (ca. 90% versus 30%). When using this process, the copolymers with MPEG 2000 block (molecular weight of PEG block: 2000 g/mol) yielded much higher efficiencies of BHb entrapment than those with MPEG 5000 block (90% versus 36%). Copolymer composition had less impact on microsphere size, but had a pronounced effect on surface morphology of microspheres. This study suggests that the W/O/W double emulsion–solvent diffusion method with EA as organic solvent is an effective process to prepare microspheres containing therapeutic proteins, and that the PELA copolymers containing MPEG 2000 block are promising wall material for biodegradable microsphere protein delivery system.     

聚[碳酸(亚丁酯-co-ε-己内酯)酯]的制备及其载药微球性能的研究

采用阴离子配位聚合方法, 合成了二氧化碳、1,2-环氧丁烷与ε-己内酯的三元共聚物: 聚[碳酸(亚丁酯-co-ε-己内酯)酯](PBCL). 并采用复相乳液(W/O/W)溶剂挥发法制备了包裹抗菌药物甲磺酸帕珠沙星的可降解微球. 对聚合物进行了FTIR, ¹H NMR, ¹³C NMR, DSC, TGA和WAXD等表征, 以及降解性能和载药微球特性的研究. 结果表明, PBCL热稳定性及降解性能优于聚碳酸亚丁酯(PBC). 所得PBCL微球球形规整、表面光滑. 大部分微球粒径在0.5～1 μm的范围内, 载药量和包封率分别达到38.21%和87.9%. 微球的体外释药性能研究在pH 7.4的磷酸缓冲溶液中进行, 释放21 d后, PBCL微球的累积释药量为84.74%, PBC微球的释药量仅为17.29%. 药物的体外释放行为符合Higuchi方程. PBCL载药微球具有长效缓释作用.     

RING-OPENING COPOLYMERIZATION OF DL-LACTIDE AND POLY(ETHYLENE GLYCOL) INITIATED BY LANTHANUM ACETATE AND APPLICATION OF THE COPOLYMER AS MATRIX OF MICROSPHERES CONTAINING VIBRIO CHOLERA ANTIGENS*

Poly-dl -lactide-poly(ethylene glycol ) (PELA) triblock copolymers were synthesized withlanthanum acetate as the initiator. PELA microspheres with entrapped Vibrio Cholera antigen and outermembrane protein (OMP) were prepared by a double emulsion W/O/W based on solvent extraction methods.The obtained microspheres showed smooth and spherical surface and their size varied between 0.5 and 5.0μm, which are suitable for oral targeting delivery system. The distribution tests in rabbits and mice throughscanning electronic micrography and fluorescence microscope indicated that microspheres have successfullyreached the immunization-related tissues, such as the liver, spleen and intestinal peyer's patches, followingoral administration. The PELA microspheres were also evaluated as an efficient antigen delivery system byenhancing a higher protective ratio against live Vibrios Cholera.     

Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique

Monodisperse poly(lactide-co-glycolide) (PLGA) microspheres containing rifampicin (RFP), anti-tubercle drug, as hydrophobic model drug were prepared by solvent evaporation method with a membrane emulsification technique using Shirasu Porous Glass (SPG) membranes. Five kinds of rifampicin-loaded PLGA (RFP/PLGA) microspheres with different sizes were prepared by changing pore size of the membranes. Effect of polyethylene glycol (PEG) added to polyvinyl alcohol (PVA) solution (continuous phase) upon the monodispersity of microspheres was studied. PEG was used as a stabilizer for microspheres dispersing in PVA solution. The most suitable molecular weight of PEG as a stabilizer was 20,000. RFP/PLGA microspheres prepared with PEG20000 were apparently more uniform than those prepared without PEG. The yield of RFP/PLGA microspheres was 100%. The initial burst observed in the release of RFP from RFP/PLGA microspheres was suppressed by the addition of PEG.     

生物可降解5-氟尿嘧啶载药微球的制备及性能研究

5-氟尿嘧啶(5-Fu)为水溶性嘧啶类抗代谢药,是治疗实体肿瘤的首选药物．但5-Fu毒性很大,血浆中停留半衰期t1／2仅为10～20min．为了减少氟尿嘧啶的毒副作用并提高药物利用率,可以将其制成聚合物载药微球．聚酯类高分子是较为常用的生物降解型药物载体材料,其中聚乳酸(PLA)及其共聚物具有良好的生物相容性及生物可降解性,常被广泛应用于药物缓释材料,     

Preparation of porous polylactide microspheres by emulsion‐solvent evaporation based on solution induced phase separation

Porous polylactide (PLA) microspheres were fabricated by an emulsion‐solvent evaporation method based on solution induced phase separation. Scanning electron microscopy (SEM) observations confirmed the porous structure of the microspheres with good connectivity. The pore size was in the range of decade micrometers. Besides large cavities as similarly existed on non‐porous microspheres, small pores were found on surfaces of the porous microspheres. The apparent density of the porous microspheres was much smaller than that of non‐porous microspheres. Fabrication conditions such as stirring rate, good solvent/non‐solvent ratio, PLA concentration and dispersant (polyvinyl alcohol, PVA) concentration had an important influence on both the particle size and size distribution and the pore size within the microspheres. A larger pore size was achieved at a slower stirring rate, lower good solvent/non‐solvent ratio or lower PLA concentration due to longer coalescence time. Copyright © 2005 John Wiley & Sons, Ltd.     

Synthesis of tetracycline‐imprinted polymer microspheres by reversible addition–fragmentation chain‐transfer precipitation polymerization using polyethylene glycol as a coporogen

Tetracycline (TC)‐imprinted microspheres have been synthesized by reversible addition–fragmentation chain‐transfer precipitation polymerization using PEG as a coporogen. In the synthesis, methacrylic acid and ethylene dimethacrylate were used as the functional monomer and cross‐linker, respectively. 2,2′‐Azobisisobutyronitrile was the initiator, and cumyl dithiobenzoate was the chain‐transfer reagent. Although monodispersed microspheres were obtained using acetonitrile as porogen, the particles cannot be used in the column extraction because of the high backpressure. To increase the porosity of the material, PEG was introduced as a coporogen. The influence of the molecular weight and concentration of PEG on the morphology, binding affinity, and porosity of the molecularly imprinted polymers (MIPs) have been studied. The results demonstrated that PEG as a macroporogen increased the porosity of the polymers. Meanwhile, the column backpressure was reduced using the MIPs with higher porosity. The binding affinity of the MIPs was increased when a low concentration of PEG was employed, while it was decreased when the ratio of PEG 12 000/monomers was >0.8%. Under the optimized conditions, TC‐imprinted microspheres with good selectivity and size uniformity have been obtained, which facilitates its application in the column extraction for TC determinations.     

尺寸可控的聚苯胺复合微球的电纺制备与表征

以十二烷基苯磺酸(DBSA)掺杂的导电聚苯胺与聚乙二醇(PEG)及Fe3O4的混合氯仿溶液,采用静电纺丝(spinning technology)方法制备含Fe3O4纳米颗粒的导电聚苯胺(PANI)/PEG/Fe3O4复合微球.SEM结果表明,电纺所得的PANI/PEG/Fe3O4复合微球结构依赖于PEG聚合物浓度、静...     

Effect of preparation temperature in solvent evaporation process on Eudragit RS microsphere properties

Eudragit RS 100 microspheres containing ketoprofen as a model drug were prepared by the solvent evaporation method using an acetone/liquid paraffin solvent system. The influence of various preparation temperatures: 10, 25, 35, and 40 degrees C, on particle size and morphology, drug content and release kinetics, and drug crystal state was evaluated. With increasing temperature, microsphere average size was found to increase and particle size distribution to widen significantly. At 10 degrees C particles of irregular shape are formed, whereas higher temperatures gradually improve the sphericity of microspheres. As can be seen from SEM photographs, particle surface roughness decreases as preparation temperature increases. It was found that temperature had no effect either on ketoprofen microencapsulation efficiency or on its crystal state, but it does influence emulsion-stabilizer incorporation. Ketoprofen forms solid solution in Eudragit matrix and maintains amorphous state for significant period of time. Drug release rates from microspheres correlated with microspheres' surface roughness and to a lesser extent with particle size.     

Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres

The instability of protein during preparation, storage, and release has become a major concern in recent years in the encapsulation of proteins into biodegradable polymers for controlled release systems. The present investigation was performed to study the mechanism of degradation of human immunoglobulin G (IgG) in double emulsion and solid-in-oil-in-water (S/O/W) encapsulation processes. The stabilizing effects of various excipients during the period of protein atomization using spray freeze-drying and subsequent encapsulation into polylactide-co-glycolide (PLGA) microspheres were explored. The size-exclusion high-performance liquid chromatography (SEC-HPLC) results showed that ultrasonication did not change the primary structure of IgG significantly. However, enzyme-linked immunosorbent assay (ELISA) revealed that the subsequent double-emulsion solvent evaporation process denatured nearly 80% of the total amount of IgG. This was possibly due to the adsorption, unfolding, and aggregation of IgG at the water/organic solvent interface. Both mannitol and trehalose could stabilize IgG during spray freeze-drying, with over 90% retention of its molecular integrity and immunoactivity, which were verified using SEC-HPLC and ELISA. Solid protein microparticles were further entrapped into monolithic-type microspheres of PLGA using the S/O/W method. FTIR results suggested that the incomplete release that is often observed in the formulation of controlled protein release systems may be due to the degradation or aggregation of protein in the solid polymer matrix.